Phone: 800-959-2846|Fax: 949-418-7287
Phone: 800-959-2846|Fax: 949-418-7287
Phone: 800-959-2846|Fax: 949-418-7287
Phone: 800-959-2846|Fax: 949-418-7287
The therascreen BRAF test enables qualitative detection of V600E mutations in the BRAF gene. It is an FDA-approved CDx assay to identify patients with cases of metastatic colorectal cancer for whom treatment with BRAFTOVI (encorafenib) in combination with cetuximab may be appropriate.
Copyright © 2024 Emeritus Medical Technology - All Rights Reserved.